A Phase Ib dose escalation study of afatinib in combination with standard-dose cetuximab in patients with advanced solid  tumours

Date 02 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Phase 1 studies: Miscellaneous drugs & targets
Topics Anti-Cancer Agents & Biologic Therapy
Presenter Emiliano Calvo